Axl receptor tyrosine kinase is a regulator of apolipoprotein E
Abstract Alzheimer’s disease (AD), the leading cause of dementia, is a chronic neurodegenerative disease. Apolipoprotein E (apoE), which carries lipids in the brain in the form of lipoproteins, plays an undisputed role in AD pathophysiology. A high-throughput phenotypic screen was conducted using a...
Main Authors: | Wenchen Zhao, Jianjia Fan, Iva Kulic, Cheryl Koh, Amanda Clark, Johan Meuller, Ola Engkvist, Samantha Barichievy, Carina Raynoschek, Ryan Hicks, Marcello Maresca, Qi Wang, Dean G. Brown, Alvin Lok, Cameron Parro, Jerome Robert, Hsien-Ya Chou, Andrea M. Zuhl, Michael W. Wood, Nicholas J. Brandon, Cheryl L. Wellington |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Molecular Brain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13041-020-00609-1 |
Similar Items
-
Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway
by: Jianjia Fan, et al.
Published: (2018-01-01) -
Decreased epidermal AXL expression and increased infiltration of AXL‐expressing dendritic cells in psoriasis
by: Yukiko Ito, et al.
Published: (2023-12-01) -
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Yeo, Xun Hui, et al.
Published: (2023) -
The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges
by: Yun Beom Sang, et al.
Published: (2022-03-01) -
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
by: Pinar Kanlikilicer, et al.
Published: (2017-12-01)